Annual EBIT:
-$98.85M-$25.87M(-35.45%)Summary
- As of today, JANX annual earnings before interest & taxes is -$98.85 million, with the most recent change of -$25.87 million (-35.45%) on December 31, 2024.
- During the last 3 years, JANX annual EBIT has fallen by -$65.92 million (-200.18%).
- JANX annual EBIT is now -2521.24% below its all-time high of -$3.77 million, reached on December 31, 2019.
Performance
JANX EBIT Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Quarterly EBIT:
-$45.12M-$10.22M(-29.29%)Summary
- As of today, JANX quarterly earnings before interest & taxes is -$45.12 million, with the most recent change of -$10.22 million (-29.29%) on June 30, 2025.
- Over the past year, JANX quarterly EBIT has dropped by -$31.30 million (-226.42%).
- JANX quarterly EBIT is now -3492.20% below its all-time high of -$1.26 million, reached on September 30, 2020.
Performance
JANX Quarterly EBIT Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
TTM EBIT:
-$144.88M-$31.30M(-27.55%)Summary
- As of today, JANX TTM earnings before interest & taxes is -$144.88 million, with the most recent change of -$31.30 million (-27.55%) on June 30, 2025.
- Over the past year, JANX TTM EBIT has dropped by -$78.95 million (-119.74%).
- JANX TTM EBIT is now -10909.04% below its all-time high of -$1.32 million, reached on March 31, 2020.
Performance
JANX TTM EBIT Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
EBIT Formula
EBIT = Revenue − COGS − Operating Expenses
JANX EBIT Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1Y1 Year | -35.5% | -226.4% | -119.7% |
| 3Y3 Years | -200.2% | -161.4% | -162.5% |
| 5Y5 Years | -2521.2% | -1819.1% | -2842.9% |
JANX EBIT Highs & Lows
| PeriodPeriod | Annual vs HighAnnual vs High | Annual vs LowAnnual vs Low | Quarter. vs HighQuarter. vs High | Quarter. vs LowQuarter. vs Low | TTM vs HighTTM vs High | TTM vs LowTTM vs Low | |
|---|---|---|---|---|---|---|---|
| 3Y | 3-Year | -200.2% | at low | -226.4% | at low | -132.5% | at low |
| 5Y | 5-Year | -2521.2% | at low | -3492.2% | at low | -2842.9% | at low |
| All-Time | All-Time | -2521.2% | at low | -3492.2% | at low | >-9999.0% | at low |
JANX EBIT History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Jun 2025 | - | -$45.12M(-29.3%) | -$144.88M(-27.6%) |
| Mar 2025 | - | -$34.90M(-20.2%) | -$113.58M(-14.9%) |
| Dec 2024 | -$98.85M(-35.4%) | -$29.02M(+19.0%) | -$98.85M(-15.0%) |
| Sep 2024 | - | -$35.84M(-159.3%) | -$85.96M(-30.4%) |
| Jun 2024 | - | -$13.82M(+31.4%) | -$65.93M(+9.5%) |
| Mar 2024 | - | -$20.16M(-24.9%) | -$72.86M(+0.2%) |
| Dec 2023 | -$72.98M(-8.8%) | -$16.14M(-2.0%) | -$72.98M(+2.8%) |
| Sep 2023 | - | -$15.81M(+23.8%) | -$75.11M(+2.9%) |
| Jun 2023 | - | -$20.75M(-2.3%) | -$77.32M(-4.7%) |
| Mar 2023 | - | -$20.28M(-11.0%) | -$73.83M(-10.0%) |
| Dec 2022 | -$67.09M | -$18.27M(-1.4%) | -$67.09M(-7.7%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2022 | - | -$18.02M(-4.4%) | -$62.31M(-12.9%) |
| Jun 2022 | - | -$17.26M(-27.5%) | -$55.20M(-24.9%) |
| Mar 2022 | - | -$13.54M(-0.4%) | -$44.19M(-34.2%) |
| Dec 2021 | -$32.93M(-400.6%) | -$13.49M(-23.7%) | -$32.93M(-56.1%) |
| Sep 2021 | - | -$10.90M(-74.4%) | -$21.09M(-84.3%) |
| Jun 2021 | - | -$6.25M(-173.7%) | -$11.45M(-51.7%) |
| Mar 2021 | - | -$2.28M(-38.0%) | -$7.55M(-14.7%) |
| Dec 2020 | -$6.58M(-74.4%) | -$1.66M(-31.8%) | -$6.58M(-33.6%) |
| Sep 2020 | - | -$1.26M(+46.6%) | -$4.92M(-34.3%) |
| Jun 2020 | - | -$2.35M(-78.6%) | -$3.67M(-178.6%) |
| Mar 2020 | - | -$1.32M | -$1.32M |
| Dec 2019 | -$3.77M | - | - |
FAQ
- What is Janux Therapeutics, Inc. annual earnings before interest & taxes?
- What is the all-time high annual EBIT for Janux Therapeutics, Inc.?
- What is Janux Therapeutics, Inc. annual EBIT year-on-year change?
- What is Janux Therapeutics, Inc. quarterly earnings before interest & taxes?
- What is the all-time high quarterly EBIT for Janux Therapeutics, Inc.?
- What is Janux Therapeutics, Inc. quarterly EBIT year-on-year change?
- What is Janux Therapeutics, Inc. TTM earnings before interest & taxes?
- What is the all-time high TTM EBIT for Janux Therapeutics, Inc.?
- What is Janux Therapeutics, Inc. TTM EBIT year-on-year change?
What is Janux Therapeutics, Inc. annual earnings before interest & taxes?
The current annual EBIT of JANX is -$98.85M
What is the all-time high annual EBIT for Janux Therapeutics, Inc.?
Janux Therapeutics, Inc. all-time high annual earnings before interest & taxes is -$3.77M
What is Janux Therapeutics, Inc. annual EBIT year-on-year change?
Over the past year, JANX annual earnings before interest & taxes has changed by -$25.87M (-35.45%)
What is Janux Therapeutics, Inc. quarterly earnings before interest & taxes?
The current quarterly EBIT of JANX is -$45.12M
What is the all-time high quarterly EBIT for Janux Therapeutics, Inc.?
Janux Therapeutics, Inc. all-time high quarterly earnings before interest & taxes is -$1.26M
What is Janux Therapeutics, Inc. quarterly EBIT year-on-year change?
Over the past year, JANX quarterly earnings before interest & taxes has changed by -$31.30M (-226.42%)
What is Janux Therapeutics, Inc. TTM earnings before interest & taxes?
The current TTM EBIT of JANX is -$144.88M
What is the all-time high TTM EBIT for Janux Therapeutics, Inc.?
Janux Therapeutics, Inc. all-time high TTM earnings before interest & taxes is -$1.32M
What is Janux Therapeutics, Inc. TTM EBIT year-on-year change?
Over the past year, JANX TTM earnings before interest & taxes has changed by -$78.95M (-119.74%)